Grant: Knowledge Synthesis Grant
McMaster University
$99,253.00
The Effect of Opioids on Chronic non-Cancer Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
FY 2011-12
Summary
Chronic non-cancer pain (CNCP) includes any painful condition that persists for 3+ months and is not associated with cancer. CNCP affects more than 10% of Canadians and narcotic pain mediation (opioids) is commonly prescribed to individuals experiencing this complaint. In Ontario the number of prescriptions for opioids rose from 3.7 million in 2005 to 4.7 million in 2008.
Despite increasing use, doctors remain divided about the benefit of opioids for CNCP. A recent study found that when family physicians in Ontario are divided into 4 equal groups based on prescribing patterns, the top 25% prescribe 55 times more opioids for CNCP than the bottom 25%. This extreme variation in prescribing of opioids means that either many CNCP patients are being denied an effective treatment, or many are being prescribed medication in which the undesirable consequences outweigh the desirable consequences - or both.
A systematic review summarizing the evidence for the benefits and harms associated with use of opioids for CNCP was published in 2006. This review guided the development of the recently released Canadian Guideline for Use of Opioids in Chronic Non-Cancer Pain. This review, however, has important limitations for informing current practices which include: (1) no studies published from May 2005 onwards are considered, (2) a sub-optimal system was used to rate the quality of evidence, and (3) the results were reported in a manner that are difficult to interpret.
We propose to conduct an updated review of studies to summarize the evidence for use of opioids to treat CNCP that will update the literature, use the strongest current methods to evaluate the quality of evidence, and present the results in a clear and transparent manner. Our proposed review will evaluate both the effectiveness and the adverse events associated with opioid use for CNCP and facilitate updating of the Canadian Guideline for Use of Opioids in Chronic Non-Cancer Pain.
Department
Program
Knowledge Synthesis Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
242610
Name
Busse Jason W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Knowledge Synthesis Grant
Projecttitle
The Effect of Opioids on Chronic non-Cancer Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$99,253
Cihrequipment2
$0
Programname2
Knowledge Synthesis Grant
Keyworddelim
Chronic Non-Cancer Pain; Opioids; Patient-Important Outcomes; Systematic Review
Abstract
Chronic non-cancer pain (CNCP) includes any painful condition that persists for 3+ months and is not associated with cancer. CNCP affects more than 10% of Canadians and narcotic pain mediation (opioids) is commonly prescribed to individuals experiencing this complaint. In Ontario the number of prescriptions for opioids rose from 3.7 million in 2005 to 4.7 million in 2008.
Despite increasing use, doctors remain divided about the benefit of opioids for CNCP. A recent study found that when family physicians in Ontario are divided into 4 equal groups based on prescribing patterns, the top 25% prescribe 55 times more opioids for CNCP than the bottom 25%. This extreme variation in prescribing of opioids means that either many CNCP patients are being denied an effective treatment, or many are being prescribed medication in which the undesirable consequences outweigh the desirable consequences - or both.
A systematic review summarizing the evidence for the benefits and harms associated with use of opioids for CNCP was published in 2006. This review guided the development of the recently released Canadian Guideline for Use of Opioids in Chronic Non-Cancer Pain. This review, however, has important limitations for informing current practices which include: (1) no studies published from May 2005 onwards are considered, (2) a sub-optimal system was used to rate the quality of evidence, and (3) the results were reported in a manner that are difficult to interpret.
We propose to conduct an updated review of studies to summarize the evidence for use of opioids to treat CNCP that will update the literature, use the strongest current methods to evaluate the quality of evidence, and present the results in a clear and transparent manner. Our proposed review will evaluate both the effectiveness and the adverse events associated with opioid use for CNCP and facilitate updating of the Canadian Guideline for Use of Opioids in Chronic Non-Cancer Pain.
Competitiondate
201110
Approvedterm2
1 yr 0 mth
Pinamesdelim
Busse, Jason W; Krawchenko, Iris E
Approvedterm
1 an 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $99,253~ $0~